tradingkey.logo

Nexalin Technology Announces Additional Positive Clinical Results In Alzheimer’S Disease With Gen-2 Sync Neurostimulation Device

ReutersOct 8, 2025 1:01 PM

- Nexalin Technology Inc NXL.O:

  • NEXALIN TECHNOLOGY ANNOUNCES ADDITIONAL POSITIVE CLINICAL RESULTS IN ALZHEIMER’S DISEASE WITH GEN-2 SYNC NEUROSTIMULATION DEVICE

  • NEXALIN TECHNOLOGY INC - NO ADVERSE EVENTS REPORTED FOR NEXALIN'S DIFS TECHNOLOGY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI